Dogwood Therapeutics DWTX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 2.8×-2.5× | 5.2×-6.4× | 11.6×+3.6× | 8×-4.3× | |
| Leverage | |||||
| Debt-to-equity | 0×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $15.05+253% | -$9.85-294% | $5.07+666% | $0.66-62.0% | |
| Valuation | |||||
| Market capitalization | $54.14M-57.6% | $43M— | —— | —— | |
| Price / book | 0.6×-16.6× | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Dogwood Therapeutics's ratios come from?
- Every ratio is computed from Dogwood Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.